324 related articles for article (PubMed ID: 27297792)
21. Overexpression of Syk tyrosine kinase in peripheral T-cell lymphomas.
Feldman AL; Sun DX; Law ME; Novak AJ; Attygalle AD; Thorland EC; Fink SR; Vrana JA; Caron BL; Morice WG; Remstein ED; Grogg KL; Kurtin PJ; Macon WR; Dogan A
Leukemia; 2008 Jun; 22(6):1139-43. PubMed ID: 18401419
[TBL] [Abstract][Full Text] [Related]
22. Peripheral T-cell lymphoma with follicular T-cell markers.
Rodríguez-Pinilla SM; Atienza L; Murillo C; Pérez-Rodríguez A; Montes-Moreno S; Roncador G; Pérez-Seoane C; Domínguez P; Camacho FI; Piris MA
Am J Surg Pathol; 2008 Dec; 32(12):1787-99. PubMed ID: 18779728
[TBL] [Abstract][Full Text] [Related]
23. Discovery and Characterization of Recurrent, Targetable ALK Fusions in Leiomyosarcoma.
Davis LE; Nusser KD; Przybyl J; Pittsenbarger J; Hofmann NE; Varma S; Vennam S; Debiec-Rychter M; van de Rijn M; Davare MA
Mol Cancer Res; 2019 Mar; 17(3):676-685. PubMed ID: 30518629
[TBL] [Abstract][Full Text] [Related]
24. The oncogenic transcription factor IRF4 is regulated by a novel CD30/NF-κB positive feedback loop in peripheral T-cell lymphoma.
Boddicker RL; Kip NS; Xing X; Zeng Y; Yang ZZ; Lee JH; Almada LL; Elsawa SF; Knudson RA; Law ME; Ketterling RP; Cunningham JM; Wu Y; Maurer MJ; O'Byrne MM; Cerhan JR; Slager SL; Link BK; Porcher JC; Grote DM; Jelinek DF; Dogan A; Ansell SM; Fernandez-Zapico ME; Feldman AL
Blood; 2015 May; 125(20):3118-27. PubMed ID: 25833963
[TBL] [Abstract][Full Text] [Related]
25. Characteristics of genetic alterations of peripheral T-cell lymphoma in childhood including identification of novel fusion genes: the Japan Children's Cancer Group (JCCG).
Ohki K; Kiyokawa N; Watanabe S; Iwafuchi H; Nakazawa A; Ishiwata K; Ogata-Kawata H; Nakabayashi K; Okamura K; Tanaka F; Fukano R; Hata K; Mori T; Moriya Saito A; Hayashi Y; Taga T; Sekimizu M; Kobayashi R;
Br J Haematol; 2021 Aug; 194(4):718-729. PubMed ID: 34258755
[TBL] [Abstract][Full Text] [Related]
26. High resolution SNP array genomic profiling of peripheral T cell lymphomas, not otherwise specified, identifies a subgroup with chromosomal aberrations affecting the REL locus.
Hartmann S; Gesk S; Scholtysik R; Kreuz M; Bug S; Vater I; Döring C; Cogliatti S; Parrens M; Merlio JP; Kwiecinska A; Porwit A; Piccaluga PP; Pileri S; Hoefler G; Küppers R; Siebert R; Hansmann ML
Br J Haematol; 2010 Feb; 148(3):402-12. PubMed ID: 19863542
[TBL] [Abstract][Full Text] [Related]
27. Intergenic Breakpoints Identified by DNA Sequencing Confound Targetable Kinase Fusion Detection in NSCLC.
Li W; Liu Y; Li W; Chen L; Ying J
J Thorac Oncol; 2020 Jul; 15(7):1223-1231. PubMed ID: 32151779
[TBL] [Abstract][Full Text] [Related]
28. Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas.
Palomero T; Couronné L; Khiabanian H; Kim MY; Ambesi-Impiombato A; Perez-Garcia A; Carpenter Z; Abate F; Allegretta M; Haydu JE; Jiang X; Lossos IS; Nicolas C; Balbin M; Bastard C; Bhagat G; Piris MA; Campo E; Bernard OA; Rabadan R; Ferrando AA
Nat Genet; 2014 Feb; 46(2):166-70. PubMed ID: 24413734
[TBL] [Abstract][Full Text] [Related]
29. [Follicular variant of peripheral T-cell lymphoma: a clinicopathologic and genetic study of 2 cases].
Zhan HQ; Zhu XZ; Li XQ; Zhou XY
Zhonghua Bing Li Xue Za Zhi; 2011 Jan; 40(1):32-6. PubMed ID: 21429356
[TBL] [Abstract][Full Text] [Related]
30. Peripheral T-Cell Lymphoma, Not Otherwise Specified: A Review of Current Disease Understanding and Therapeutic Approaches.
Al-Zahrani M; Savage KJ
Hematol Oncol Clin North Am; 2017 Apr; 31(2):189-207. PubMed ID: 28340873
[TBL] [Abstract][Full Text] [Related]
31. Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma.
Heavican TB; Bouska A; Yu J; Lone W; Amador C; Gong Q; Zhang W; Li Y; Dave BJ; Nairismägi ML; Greiner TC; Vose J; Weisenburger DD; Lachel C; Wang C; Fu K; Stevens JM; Lim ST; Ong CK; Gascoyne RD; Missiaglia E; Lemonnier F; Haioun C; Hartmann S; Pedersen MB; Laginestra MA; Wilcox RA; Teh BT; Yoshida N; Ohshima K; Seto M; Rosenwald A; Ott G; Campo E; Rimsza LM; Jaffe ES; Braziel RM; d'Amore F; Inghirami G; Bertoni F; de Leval L; Gaulard P; Staudt LM; McKeithan TW; Pileri S; Chan WC; Iqbal J
Blood; 2019 Apr; 133(15):1664-1676. PubMed ID: 30782609
[TBL] [Abstract][Full Text] [Related]
32. The ITK-SYK fusion oncogene induces a T-cell lymphoproliferative disease in mice mimicking human disease.
Dierks C; Adrian F; Fisch P; Ma H; Maurer H; Herchenbach D; Forster CU; Sprissler C; Liu G; Rottmann S; Guo GR; Katja Z; Veelken H; Warmuth M
Cancer Res; 2010 Aug; 70(15):6193-204. PubMed ID: 20670954
[TBL] [Abstract][Full Text] [Related]
33. Mutations Affecting Genes in the Proximal T-Cell Receptor Signaling Pathway in Peripheral T-Cell Lymphoma.
Liu X; Ning J; Liu X; Chan WCJ
Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35954378
[TBL] [Abstract][Full Text] [Related]
34. Small nucleolar RNA expression profiling identifies potential prognostic markers in peripheral T-cell lymphoma.
Valleron W; Ysebaert L; Berquet L; Fataccioli V; Quelen C; Martin A; Parrens M; Lamant L; de Leval L; Gisselbrecht C; Gaulard P; Brousset P
Blood; 2012 Nov; 120(19):3997-4005. PubMed ID: 22990019
[TBL] [Abstract][Full Text] [Related]
35. Proteomic profiling identifies outcome-predictive markers in patients with peripheral T-cell lymphoma, not otherwise specified.
Ludvigsen M; Bjerregård Pedersen M; Lystlund Lauridsen K; Svenstrup Poulsen T; Hamilton-Dutoit SJ; Besenbacher S; Bendix K; Møller MB; Nørgaard P; d'Amore F; Honoré B
Blood Adv; 2018 Oct; 2(19):2533-2542. PubMed ID: 30291111
[TBL] [Abstract][Full Text] [Related]
36. Cytotoxic protein expression in natural killer cell lymphomas and in alpha beta and gamma delta peripheral T-cell lymphomas.
Boulland ML; Kanavaros P; Wechsler J; Casiraghi O; Gaulard P
J Pathol; 1997 Dec; 183(4):432-9. PubMed ID: 9496260
[TBL] [Abstract][Full Text] [Related]
37. Molecular Pathogenesis of Peripheral T Cell Lymphoma.
Sakata-Yanagimoto M; Chiba S
Curr Hematol Malig Rep; 2015 Dec; 10(4):429-37. PubMed ID: 26431836
[TBL] [Abstract][Full Text] [Related]
38. The aggressive peripheral T-cell lymphomas: 2015.
Armitage JO
Am J Hematol; 2015 Jul; 90(7):665-73. PubMed ID: 26031230
[TBL] [Abstract][Full Text] [Related]
39. Pathobiology and molecular profiling of peripheral T-cell lymphomas.
de Leval L; Gaulard P
Hematology Am Soc Hematol Educ Program; 2008; ():272-9. PubMed ID: 19074096
[TBL] [Abstract][Full Text] [Related]
40. Distinct morphologic, phenotypic, and clinical-course characteristics of indolent peripheral T-cell lymphoma.
Hayashi E; Takata K; Sato Y; Tashiro Y; Tachiyama Y; Sawada-Kitamura S; Hiramatsu Y; Sugiguchi S; Nose S; Hirokawa M; Ando M; Abd Alkader L; Maeda Y; Tanimoto M; Yoshino T
Hum Pathol; 2013 Sep; 44(9):1927-36. PubMed ID: 23706909
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
